HeartSine to Present Research Findings on Novel CPR Advisor Technology

Dr Peter O’Hare of HeartSine’s Clinical Engineering Research Group has been invited to present research on the company’s patented CPR Advisor platform at Resuscitation 2014, the Congress of the European Resuscitation Council (ERC).

During his presentation entitled “The Correlation between the Impedance Cardiogram and End-tidal Carbon Dioxide during Cardiopulmonary Resuscitation in Cardiac Arrest,” Dr O’Hare will discuss how CPR Advisor can be used to measure the effectiveness of CPR during a resuscitation attempt.  The findings of the research will demonstrate how the technology, which is incorporated into the company’s samaritan PAD 500P AEDs (Automated External Defibrillators), has been shown to relate directly to vital sign measurements such as end-tidal CO2 (carbon dioxide), blood oxygen levels and blood pressure.

The ERC is the author of the current and future European Resuscitation Guidelines and the annual ERC conference is the main forum for the discussion of all things relating to resuscitation.

“This is a great opportunity for HeartSine to show how its industry-leading research can be used to save the lives of those who suffer sudden cardiac arrest,” says Declan O’Mahoney, CEO of HeartSine Technologies.  “It’s an honor for a member of our clinical team to be selected to speak at this prestigious event.”

During Resuscitation 2014, held in Bilbao, Spain on 15-17 May 2014, HeartSine will demonstrate its samaritan PAD AEDs on stand B24 at the scientific and technical exhibition.